The Mullings Group published a first-in-human study in JACC Cardiovascular Interventions evaluating Tulyp Medical's pressure-controlled, flow-regulating extracorporeal limb perfusion technology.
Public source
Publisher name
Public post
We may be watching the standard of care for limb protection begin to change. Today, patients undergoing VA-ECMO and other large-bore femoral access procedures are typica…
Company
The Mullings Group
Building companies and careers for over three decades.
- Industry
- Technology, Information and Internet
- Location
- Delray Beach, US
- Company size
- 51–200 employees
About The Mullings Group
In 1992, The Mullings Group decided to go “all in” on technology and medical devices because people were not only living longer but wanting to live healthier and we know tech would always seek a higher ground. Since then, we have successfully completed more than 9,000 searches in the medtech / healthtech / life sciences industry with over 900 companies globally. Our search team has a combined tenure of over 100+ years with TMG — a rare indicator of success, commitment, and consistency. As the only search firm in the world with a full media and marketing arm in our organization, we understand how critical it is to tell our clients stories at scale to support Attention & Awareness, M&A, Recruiting & Talent Access for emerging technology companies. Our 9-time Award-Winning media and production company, Dragonfly, has created content for some of the most successful medtech organizations in the world. Who brings your message to market matters and so does their reach. We have established ourselves as the “voice of the industry” in developing companies and careers. With over 300,000+ sets of eyes on us every day on career platforms like LinkedIn, where careers are built, we are the trusted partner in the industry. TMG is headquartered in Delray Beach, FL with offices in the US, the UK, and Israel. As we continue to expand our search practices nationally and internationally, we continue to grow in medtech / life sciences and emerging high tech industries.
See moreLatest activity
Latest activity from The Mullings Group
14 signals
Customers & Market
The Mullings Group noted that August 2026 was the slowdown that never happened for Med Tech.
Presence & Recognition
The Mullings Group is attending the LSI Barcelona event hosted by the Shifamed team of Amr Salahieh, Mariam Maghribi, and Kavi Vyas to discuss how AI will bring analog devices into the future.
Customers & Market
The Mullings Group closed 30 placements across the medicaldevice industry spanning cardiology, surgical robotics, neurology, vascular, digital health, oncology, orthopedics, nephrology, organ preservation, manufacturing, patient care, third party logistics, and clinical research in August.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Endologix LLC
Endologix LLC published a report from a retrospective independent study in the May 2026 issue of JVS-Vascular Insights demonstrating 10-year durability for the Ovation stent graft with Adaptive Sealing Technology.
Research & Knowledge
Getinge
Getinge published recent studies demonstrating that prophylactic IABP support provides crucial hemodynamic stabilization in patients with advanced heart failure undergoing high-risk structural heart procedures such as MitraClip and TAVI.
Research & Knowledge
Single Pass, Inc.
Single Pass, Inc. published a retrospective multicenter study of the SinglePass biopsy closure device at Hoag Health System across 120 consecutive patients with 30-day follow-up showing 100% technical success and zero clinically significant bleeding events.
Research & Knowledge
Translumina
Translumina enrolled 100 patients in the SPARX Trial to generate clinical evidence for drug-coated balloon therapy in complex vessels.
Research & Knowledge
ASAHI INTECC USA, Inc. Medical Sales